Why a Single Seizure Still Counts

Key Takeaways:

• Even a breakthrough seizure should prompt reassessment rather than be dismissed as an isolated event because individual seizures carry cumulative risks, including injury, premature mortality, and sudden unexpected death in epilepsy.
• Mortality in epilepsy runs roughly 2 to 3 times that of the general population and is concentrated in patients with uncontrolled seizures.
• Acute seizure episodes are a legitimate point of clinical intervention, and reducing seizure burden is associated with reduced risk.

A breakthrough seizure in a patient who has otherwise been doing well can be tempting to view as an isolated setback rather than evidence that the treatment plan deserves reassessment. The epidemiology argues for reexamining that view. Individual seizures, particularly when they recur or occur in clusters, carry cumulative risks that accrue quietly, and several of the most serious are potentially modifiable.

The cumulative risk case

Injury is the most immediate concern. Seizure-related injuries are more common in people with epilepsy than in the general population, and while most are non-fatal, the recurring types – burns, fractures, soft-tissue injuries, submersion events, and motor-vehicle accidents – can be serious and, in some cases, life-threatening.¹

Although many seizure-related injuries are minor, the cumulative burden becomes clinically meaningful over time, particularly in patients with ongoing seizures. A person with epilepsy carries an appreciable annual chance of a seizure-related injury, and submersion and motor-vehicle events are among the most feared precisely because of their potential lethality.¹

The mortality signal is clearer still: Across population-based cohorts, the standardized mortality ratio for people with epilepsy is elevated, with a weighted median around 2.3 and estimates ranging from roughly 1.6 to 3.0, with the highest risk seen among patients with ongoing generalized tonic-clonic seizures and persistent uncontrolled epilepsy.²

Sudden unexpected death in epilepsy (SUDEP) sits within this picture as a leading category of epilepsy-related death. It affects about 1 in 1,000 adults with epilepsy per year, although the absolute risk varies considerably depending on seizure control and other clinical factors. Its major risk factor is the occurrence of generalized tonic-clonic seizures, and the risk increases as those seizures become more frequent.³

These risks are greatest in patients with ongoing uncontrolled seizures, reinforcing that seizure control is important not only for quality of life but also for long-term safety.

When clusters escalate

Beyond the cumulative view, acute episodes carry their own time-sensitive risk. Seizure clusters may progress toward status epilepticus, and prolonged seizures become both harder to stop and more likely to cause neuronal injury the longer they continue.⁴

As seizures persist, synaptic receptor changes make them more difficult to terminate pharmacologically while increasing the risk of neuronal injury.⁵

Convulsive status epilepticus is now defined at 5 minutes of continuous seizure activity precisely because prompt treatment at that point improves the likelihood of seizure termination and reduces the risk of complications. For appropriate patients, seizure clusters represent an opportunity for early intervention before progression to more prolonged seizures.⁵

Acting on acute episodes

Taken together, these risks reframe the isolated seizure. A breakthrough seizure should prompt reassessment of potentially reversible contributors such as medication adherence, recent illness, sleep deprivation, alcohol use, metabolic disturbances, or interacting medications before concluding that the patient's epilepsy has simply progressed. Achieving better seizure control, particularly freedom from generalized tonic-clonic seizures, is associated with lower SUDEP risk, making seizure reduction an important safety goal in addition to improving quality of life.³

Acting on acute episodes is part of that goal. For patients who are appropriate candidates, an individualized seizure action plan, including a rescue benzodiazepine by an appropriate route, gives patients a way to interrupt a cluster before it escalates. Recognizing seizure clusters early and ensuring that appropriate patients have a clear seizure action plan can help reduce delays in treatment and improve overall seizure preparedness.⁶